Works by Chan, Wah-Kheong
Results: 63
Non-invasive assessment of metabolic dysfunction–associated fatty liver disease.
- Published in:
- Therapeutic Advances in Endocrinology & Metabolism, 2022, p. 1, doi. 10.1177/20420188221139614
- By:
- Publication type:
- Article
Association between non‐alcoholic fatty liver disease evaluated by transient elastography with extracranial carotid atherosclerosis in a multiethnic Asian community.
- Published in:
- JGH Open, 2019, v. 3, n. 2, p. 117, doi. 10.1002/jgh3.12114
- By:
- Publication type:
- Article
Epidemiology of non‐alcoholic fatty liver disease‐related hepatocellular carcinoma and its implications.
- Published in:
- JGH Open, 2018, v. 2, n. 5, p. 235, doi. 10.1002/jgh3.12070
- By:
- Publication type:
- Article
Is metabolic‐dysfunction‐associated fatty liver disease or advanced liver fibrosis associated with erythropoietin stimulating agent hypo‐responsiveness among patients with end‐stage kidney disease on haemodialysis?
- Published in:
- Nephrology, 2023, v. 28, n. 8, p. 425, doi. 10.1111/nep.14186
- By:
- Publication type:
- Article
Endoscopic sleeve gastroplasty: Case report, technique and literature review.
- Published in:
- Journal of Digestive Diseases, 2017, v. 18, n. 10, p. 598, doi. 10.1111/1751-2980.12548
- By:
- Publication type:
- Article
Sustained complete remission of advanced hepatocellular carcinoma with sorafenib therapy.
- Published in:
- Journal of Digestive Diseases, 2015, v. 16, n. 9, p. 537, doi. 10.1111/1751-2980.12270
- By:
- Publication type:
- Article
Progression of liver disease in non-alcoholic fatty liver disease: A prospective clinicopathological follow-up study.
- Published in:
- Journal of Digestive Diseases, 2014, v. 15, n. 10, p. 545, doi. 10.1111/1751-2980.12175
- By:
- Publication type:
- Article
Clinical outcomes and direct costings of endoluminal clipping compared to surgery in the management of iatrogenic colonic perforation.
- Published in:
- Journal of Digestive Diseases, 2013, v. 14, n. 12, p. 670, doi. 10.1111/1751-2980.12097
- By:
- Publication type:
- Article
Metabolic dysfunction‐associated fatty liver disease (MAFLD) and advanced liver fibrosis among hemodialysis patients in a multiethnic urban population in Malaysia.
- Published in:
- Seminars in Dialysis, 2023, v. 36, n. 2, p. 107, doi. 10.1111/sdi.13117
- By:
- Publication type:
- Article
Response to letter to editor: Potential impact of Helicobacter pylori infection on hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B.
- Published in:
- Journal of Viral Hepatitis, 2023, v. 30, n. 8, p. 712, doi. 10.1111/jvh.13858
- By:
- Publication type:
- Article
Clinical and patient‐reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™.
- Published in:
- Journal of Viral Hepatitis, 2023, v. 30, n. 4, p. 335, doi. 10.1111/jvh.13800
- By:
- Publication type:
- Article
Hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B: The multicentre, prospective CAP‐Asia study.
- Published in:
- Journal of Viral Hepatitis, 2023, v. 30, n. 4, p. 319, doi. 10.1111/jvh.13796
- By:
- Publication type:
- Article
Fatty liver is associated with advanced fibrosis but does not predict adverse outcomes in patients with chronic hepatitis B.
- Published in:
- Journal of Viral Hepatitis, 2020, v. 27, n. 12, p. 1297, doi. 10.1111/jvh.13361
- By:
- Publication type:
- Article
Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: the GOASIA study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Use of simple scoring systems for a public health approach in the management of non‐alcoholic fatty liver disease patients.
- Published in:
- JGH Open, 2020, v. 4, n. 6, p. 1155, doi. 10.1002/jgh3.12414
- By:
- Publication type:
- Article
Epidemiological differences of common liver conditions between Asia and the West.
- Published in:
- JGH Open, 2020, v. 4, n. 3, p. 332, doi. 10.1002/jgh3.12275
- By:
- Publication type:
- Article
Limited applicability of cathepsin D for the diagnosis and monitoring of non‐alcoholic steatohepatitis.
- Published in:
- JGH Open, 2019, v. 3, n. 5, p. 417, doi. 10.1002/jgh3.12178
- By:
- Publication type:
- Article
Endoscopic management of colonoscopy-related perforation.
- Published in:
- Journal of Digestive Endoscopy, 2018, v. 9, n. 2, p. 47, doi. 10.4103/jde.JDE_74_17
- By:
- Publication type:
- Article
Attenuation parameter and liver stiffness measurement using FibroTouch vs Fibroscan in patients with chronic liver disease.
- Published in:
- PLoS ONE, 2021, v. 16, n. 5, p. 1, doi. 10.1371/journal.pone.0250300
- By:
- Publication type:
- Article
Diagnostic accuracy of non‐invasive tests to screen for at‐risk MASH—An individual participant data meta‐analysis.
- Published in:
- Liver International, 2024, v. 44, n. 8, p. 1872, doi. 10.1111/liv.15914
- By:
- Publication type:
- Article
Meaning of non‐overlapping patients between the MAFLD and NAFLD definitions.
- Published in:
- Liver International, 2022, v. 42, n. 2, p. 271, doi. 10.1111/liv.15142
- By:
- Publication type:
- Article
Unhealthy lifestyle habits and physical inactivity among Asian patients with non‐alcoholic fatty liver disease.
- Published in:
- Liver International, 2020, v. 40, n. 11, p. 2719, doi. 10.1111/liv.14638
- By:
- Publication type:
- Article
Reply to: CHAI and MACK‐3 as noninvasive indices for nonalcoholic steatohepatitis.
- Published in:
- Liver International, 2019, v. 39, n. 8, p. 1588, doi. 10.1111/liv.14139
- By:
- Publication type:
- Article
MACK‐3 (combination of hoMa, Ast and CK18): A promising novel biomarker for fibrotic non‐alcoholic steatohepatitis.
- Published in:
- Liver International, 2019, v. 39, n. 7, p. 1315, doi. 10.1111/liv.14084
- By:
- Publication type:
- Article
Copy number variation in exportin-4 (XPO4) gene and its association with histological severity of non-alcoholic fatty liver disease.
- Published in:
- Scientific Reports, 2015, p. 13306, doi. 10.1038/srep13306
- By:
- Publication type:
- Article
Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in non-alcoholic fatty liver disease.
- Published in:
- PLoS ONE, 2017, v. 12, n. 4, p. 1, doi. 10.1371/journal.pone.0174982
- By:
- Publication type:
- Article
Vitamin E improves serum markers and histology in adults with metabolic dysfunction‐associated steatotic liver disease: Systematic review and meta‐analysis.
- Published in:
- Journal of Gastroenterology & Hepatology, 2024, v. 39, n. 12, p. 2545, doi. 10.1111/jgh.16723
- By:
- Publication type:
- Article
LIVERSTAT for risk stratification for patients with metabolic dysfunction‐associated fatty liver disease.
- Published in:
- Journal of Gastroenterology & Hepatology, 2024, v. 39, n. 10, p. 2182, doi. 10.1111/jgh.16675
- By:
- Publication type:
- Article
Metabolic fatty liver syndromes: where do we stand in 2024?
- Published in:
- Journal of Gastroenterology & Hepatology, 2024, v. 39, n. 4, p. 613, doi. 10.1111/jgh.16507
- By:
- Publication type:
- Article
Frequency of significant steatosis and compensated advanced chronic liver disease among adults with chronic liver disease.
- Published in:
- Journal of Gastroenterology & Hepatology, 2023, v. 38, n. 10, p. 1818, doi. 10.1111/jgh.16313
- By:
- Publication type:
- Article
Epidemiological trends of gastrointestinal and liver diseases in Malaysia: A single‐center observational study.
- Published in:
- Journal of Gastroenterology & Hepatology, 2022, v. 37, n. 9, p. 1732, doi. 10.1111/jgh.15905
- By:
- Publication type:
- Article
Reliability of the nonalcoholic steatohepatitis clinical research network and steatosis activity fibrosis histological scoring systems.
- Published in:
- Journal of Gastroenterology & Hepatology, 2022, v. 37, n. 6, p. 1131, doi. 10.1111/jgh.15843
- By:
- Publication type:
- Article
Malaysian Society of Gastroenterology and Hepatology consensus statement on metabolic dysfunction‐associated fatty liver disease.
- Published in:
- Journal of Gastroenterology & Hepatology, 2022, v. 37, n. 5, p. 795, doi. 10.1111/jgh.15787
- By:
- Publication type:
- Article
Modest alcohol intake not associated with significant hepatic steatosis or more severe liver disease among patients with diabetes mellitus.
- Published in:
- Journal of Gastroenterology & Hepatology, 2021, v. 36, n. 3, p. 751, doi. 10.1111/jgh.15160
- By:
- Publication type:
- Article
Development and validation of a novel non‐invasive test for diagnosing fibrotic non‐alcoholic steatohepatitis in patients with biopsy‐proven non‐alcoholic fatty liver disease.
- Published in:
- Journal of Gastroenterology & Hepatology, 2020, v. 35, n. 10, p. 1804, doi. 10.1111/jgh.15055
- By:
- Publication type:
- Article
Liver stiffness measurement in non‐alcoholic fatty liver disease: Two is better than one.
- Published in:
- Journal of Gastroenterology & Hepatology, 2020, v. 35, n. 8, p. 1404, doi. 10.1111/jgh.14978
- By:
- Publication type:
- Article
Suboptimal treatment of dyslipidemia in patients with nonalcoholic fatty liver disease.
- Published in:
- Journal of Gastroenterology & Hepatology, 2020, v. 35, n. 2, p. 320, doi. 10.1111/jgh.14794
- By:
- Publication type:
- Article
Comparing point shear wave elastography (ElastPQ) and transient elastography for diagnosis of fibrosis stage in non‐alcoholic fatty liver disease.
- Published in:
- Journal of Gastroenterology & Hepatology, 2020, v. 35, n. 1, p. 135, doi. 10.1111/jgh.14782
- By:
- Publication type:
- Article
Screening for non‐alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography.
- Published in:
- Journal of Gastroenterology & Hepatology, 2019, v. 34, n. 8, p. 1396, doi. 10.1111/jgh.14577
- By:
- Publication type:
- Article
Can the same controlled attenuation parameter cut‐offs be used for M and XL probes for diagnosing hepatic steatosis?
- Published in:
- Journal of Gastroenterology & Hepatology, 2018, v. 33, n. 10, p. 1787, doi. 10.1111/jgh.14150
- By:
- Publication type:
- Article
The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 2: Management and special groups.
- Published in:
- Journal of Gastroenterology & Hepatology, 2018, v. 33, n. 1, p. 86, doi. 10.1111/jgh.13856
- By:
- Publication type:
- Article
Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment.
- Published in:
- Journal of Gastroenterology & Hepatology, 2018, v. 33, n. 1, p. 70, doi. 10.1111/jgh.13857
- By:
- Publication type:
- Article
Oxidized low-density lipoprotein in non-alcoholic steatohepatitis.
- Published in:
- 2016
- By:
- Publication type:
- Editorial
Asian consensus on the relationship between obesity and gastrointestinal and liver diseases.
- Published in:
- Journal of Gastroenterology & Hepatology, 2016, v. 31, n. 8, p. 1405, doi. 10.1111/jgh.13385
- By:
- Publication type:
- Article
Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease.
- Published in:
- Journal of Gastroenterology & Hepatology, 2014, v. 29, n. 7, p. 1470, doi. 10.1111/jgh.12557
- By:
- Publication type:
- Article
Non-alcoholic fatty liver disease in diabetics - prevalence and predictive factors in a multiracial hospital clinic population in Malaysia.
- Published in:
- Journal of Gastroenterology & Hepatology, 2013, v. 28, n. 8, p. 1375, doi. 10.1111/jgh.12204
- By:
- Publication type:
- Article
Non-invasive assessment of metabolic dysfunction–associated fatty liver disease.
- Published in:
- Therapeutic Advances in Endocrinology & Metabolism, 2022, p. 1, doi. 10.1177/20420188221139614
- By:
- Publication type:
- Article
Validation study of the Leeds Dyspepsia Questionnaire in a multi-ethnic Asian population.
- Published in:
- Journal of Gastroenterology & Hepatology, 2011, v. 26, n. 11, p. 1669, doi. 10.1111/j.1440-1746.2011.06806.x
- By:
- Publication type:
- Article
Diagnosis and non‐invasive assessment of MASLD in type 2 diabetes and obesity.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. S23, doi. 10.1111/apt.17866
- By:
- Publication type:
- Article
Machine learning improves the prediction of significant fibrosis in Asian patients with metabolic dysfunction‐associated steatotic liver disease – The Gut and Obesity in Asia (GO‐ASIA) Study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 6, p. 774, doi. 10.1111/apt.17891
- By:
- Publication type:
- Article